IMGT Invests $500K in US Subsidiary for FDA Clinical Trial Management
IMGT (456570) announced on May 7, 2026 via DART that it will invest $500,000 (approximately $344K USD equivalent) in IMGT USA, Inc., its 100% subsidiary based in Virginia, to manage FDA-regulated clinical trials and establish direct product distribution and sales channels in the US market.